These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7348568)

  • 1. Combined chemo-hormonal therapy in breast cancer: a hypothesis.
    Osborne CK
    Breast Cancer Res Treat; 1981; 1(2):121-3. PubMed ID: 7348568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer.
    Carter SK
    Breast Cancer Res Treat; 1981; 1(1):43-51. PubMed ID: 6184098
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II clinical study of high-dose toremifene in patients with advanced breast cancer.
    Modig H; Borgström S; Nilsson I; Westman G
    J Steroid Biochem; 1990 Jun; 36(3):237-8. PubMed ID: 2142243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen in early breast cancer.
    Bryce CJ
    Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
    [No Abstract]   [Full Text] [Related]  

  • 7. [For how long should breast cancer patients take Tamoxifen? The International Program ATLAS will answer this question].
    Semiglazov VF
    Vopr Onkol; 1998; 44(4):373-7. PubMed ID: 9807196
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen in early breast cancer.
    Saibara T; Ogawa Y; Onishi S
    Lancet; 1998 Aug; 352(9125):404. PubMed ID: 9717954
    [No Abstract]   [Full Text] [Related]  

  • 9. Five years of tamoxifen--or more?
    Peto R
    J Natl Cancer Inst; 1996 Dec; 88(24):1791-3. PubMed ID: 8961965
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years.
    Love RR; Olsen MR; Havighurst TC
    J Natl Cancer Inst; 1999 Jul; 91(13):1167-8. PubMed ID: 10393732
    [No Abstract]   [Full Text] [Related]  

  • 11. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiestrogen therapy in the treatment of breast neoplasms].
    Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
    Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients.
    Rae JM
    Clin Pharmacol Ther; 2013 Aug; 94(2):183-5. PubMed ID: 23872830
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
    Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
    J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of chemo-endocrine therapy in advanced breast cancer--a combined administration of tamoxifen, tegafur, and cyclophosphamide].
    Wada T; Koyama H; Nishizawa Y; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2093-100. PubMed ID: 6820378
    [No Abstract]   [Full Text] [Related]  

  • 16. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced breast cancer successfully treated with combined tamoxifen and epitiostanol].
    Konishi Y; Morimoto T; Komaki K; Yamakawa T; Mituyama N; Tanaka T; Oomine Y; Monden Y
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2163-7. PubMed ID: 3395140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential endocrine therapy and chemotherapy in metastatic breast cancer: effects on survival.
    Manni A; Pearson OH; Marshall JS; Arafah BM
    Breast Cancer Res Treat; 1981; 1(2):97-103. PubMed ID: 6184099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.
    J Natl Cancer Inst; 1996 Dec; 88(24):1834-9. PubMed ID: 8961973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endocrine manipulations and chemotherapy in the management of breast cancer.
    Clarysse A
    Acta Clin Belg Suppl; 1986; 11():49-62. PubMed ID: 3459323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.